Substituent elimination from p-substituted phenols by cytochrome P450 ipso-substitution by the oxygen atom of the active species

Drug Metabolism and Disposition

Volumn 25, Issue 1, 1997, Pages 116-122

  Ohe, Tomoyuki ^b   Mashino, Tadahiko ^a   Hirobe, Masaaki ^b  

^a KEIO UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; HYDROQUINONE; PHENOL DERIVATIVE;

ANIMAL TISSUE; ARTICLE; DRUG HYDROXYLATION; DRUG METABOLISM; DRUG SAFETY; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CARBON MONOXIDE; CYTOCHROME P-450 ENZYME SYSTEM; ISOENZYMES; MALE; METYRAPONE; MICROSOMES, LIVER; OXYGEN ISOTOPES; PHENOLS; RATS; RATS, WISTAR;

EID: 0031012608     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. F. P. Guengerich and T. L. Macdonald: Chemical mechanisms of catalysis by cytochromes P-450: a unified view. Acc. Chem. Res. 17, 9-16 (1984).
2. F. P. Guengerich: Reactions and significance of cytochrome P-450 enzymes. J. Biol. Chem. 266, 10019-10022 (1991).
3. T. D. Porter and M. J. Coon: Cytochrome P-450. J. Biol. Chem. 266, 13469-13472 (1991).
4. F. P. Guengerich: Cytochrome P450: advances and prospects. FASEB J. 6, 667-668 (1992).
5. M. J. Coon, X. Ding, S. J. Pernecky, and A. D. N. Vaz: Cytochrome P450: progress and predictions. FASEB J. 6, 669-673 (1992).
6. M. R. Waterman, M. E. John, and E. R. Simpson: Regulation of synthesis and activity of cytochrome P-450 enzymes in physiological pathway. In "Cytochrome P-450, Structure, Mechanism, and Biochemistry" (P. R. Ortiz de Montellano, ed.), pp. 345-386. Plenum Press, New York, 1986.
7. B. Meunier: Metalloporphyrins as versatile catalysts for oxidation reactions and oxidative DNA cleavage. Chem. Rev. 92, 1411-1456 (1992).
8. H. Masumoto, K. Takeuchi, S. Ohta, and M. Hirobe: Application of chemical P450 model systems to studies on drug metabolism. I. Phencyclidine: a multi-functional model substrate. Chem. Pharm. Bull. 37, 1788-1794 (1989).
9. Y. Nagatsu, T. Higuchi, and M. Hirobe: Facile preparation of unstable metabolic intermediates; epoxide(s) of pyrazolo[1,5-a]pyridine derivatives by the cytochrome P-450 chemical model. Chem. Pharm. Bull. 37, 1410-1412 (1989).
10. Y. Nagatsu, T. Higuchi, and M. Hirobe: Application of chemical P-450 model systems to study drug metabolism. III. Metabolism of isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine. Chem. Pharm. Bull. 38, 400-403 (1990).
11. H. Masumoto, S. Ohta, and M. Hirobe: Application of chemical cytochrome P-450 model systems to studies on drug metabolism. IV. Mechanism of piperidine metabolism pathway via an iminium intermediate. Drug Metab. Dispos. 19, 768-780 (1991).
12. M. Komuro, Y. Nagatsu, T. Higuchi, and M. Hirobe: Oxidative decarboxylation of carboxylic acids by iron porphyrin-idosylbenzene system. Tetrahedron Lett. 33, 4949-4952 (1992).
13. T. Doi, T. Mori, T. Mashino, and M. Hirobe: Application of chemical cytochrome P-450 model systems to studies on drug metabolism. VI. N,N-Coupling reaction of N-methylaniline catalyzed by polypeptide-bound porphyrinatoiron(III) and cytochrome P-450. Biochem. Biophys. Res. Commun. 191, 737-743 (1993).
14. T. Ohe, T. Mashino, and M. Hirobe: Novel metabolic pathway of arylethers by cytochrome P450: cleavage of the oxygen-aromatic ring bond accompanying ipso-substitution by the oxygen atom of the active species in cytochrome P450 models and cytochrome P450. Arch. Biochem. Biophys. 19, 402-409 (1994).
15. M. Komuro, T. Higuchi, and M. Hirobe: Application of chemical cytochrome P-450 model systems to studies on drug metabolism. VIII. Novel metabolism of carboxylic acids via oxidative decarboxylation. Bioorg. Med. Chem. 3, 55-65 (1995).
16. T. Ohe, T. Mashino, and M. Hirobe: Novel oxidative pathway of parasubstituted phenols in cytochrome P450 chemical model: substituent elimination accompanying ipso-substitution by the oxygen atom of the active species. Tetrahedron Lett. 42, 7681-7684 (1995).
17. M. Komuro, T. Higuchi, and M. Hirobe: Application of chemical P-450 model systems to studies on drug metabolism. Part X. Novel hydroxylactonization of γ, δ-and β, γ-unsaturated carboxylic acids with an iron porphyrin-iodosylbenzene system. J. Chem. Soc., 1, 2309-2313 (1996).
18. S. D. Nelson: Metabolic activation and drug toxicity. J. Med. Chem. 25, 753-765 (1982).
19. F. J. Gonzalez and H. V. Gelboin: Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metab. Rev. 26, 165-183 (1994).
20. B. K. Park and N. R. Kitteringham: Effects of fluorine substitution on drug metabolism: pharmacological and toxicological implications. Drug Metab. Rev. 26, 605-643 (1994).
21. J. J. Li, R. H. Purdy, E. H. Appelman, J. K. Klicka, and S. A. Li: Catechol formation of fluoro-and bromo-substituted estradiols by hamster liver microsomes. Mol. Pharmacol. 27, 559-565 (1985).
22. G. Renner and C. Hopfer: Metabolic studies on pentachlorophenol (PCP) in rats. Xenobiotica 20, 573-582 (1990).
23. I. M. C. M. Rietjens and J. Vervoort: A new hypothesis for the mechanism for cytochrome P-450 dependent aerobic conversion of hexahalogenated benzenes to pentahalogenated phenols. Chem. Res. Toxicol. 5, 10-19 (1992).
24. C. Den Besten, P. J. Van Bladeren, E. Duizer, J. Vervoort, and I. M. C. M. Rietjens: Cytochrome P450-mediated oxidation of pentafluorophenol to tetrafluorobenzoquinone as the primary reaction product. Chem. Res. Toxicol. 6, 674-680 (1993).
25. K. Endo, K. Seya, and H. Hikono: Biogenesis-like transformation of salidroside to rengyol and its related cyclohexyletanoids of Forsythia suspensa. Tetrahedron 45, 3673-3682 (1989).
26. C. A. Bunton and J. Hellyer: The oxidative hydrolysis of quinol esters by periodic acid. J. Am. Chem. Soc. 89, 6252-6257 (1967).
27. N. G. Gaylord and P. M. Kamath: p-Chlorophenyl salicylate. In "Organic Syntheses" (N. Rabjohn, ed.), vol. 4, pp. 178-179. John Wiley and Sons, New York, 1963.
28. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275 (1951).
29. T. Omura and R. Sato: The carbon monoxide-binding pigment of liver microsomes. J. Biol. Chem. 239, 2370-2378 (1964).
30. T. Nash: The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem. J. 55, 416-421 (1953).
31. J. Werringloer: Assay of formaldehyde generated during microsomal oxidation reactions. In "Methods in Enzymology" (S. Fleischer and L. Packer, eds.), vol. 52, pp. 297-302. Academic Press, New York, 1978.
32. P. Griess: Bemerkungen zu der Abhandlung der HH. Weselsky und Benedikt "Ueber einige Azoverbindungen." Chem. Ber. 12, 426-428 (1879).
33. T. P. Misko, R. J. Schilling, D. Salvemini, W. M. Moore, and M. G. Currie: A fluorometric assay for the measurement of nitrite in biological samples. Anal. Biochem. 214, 11-16 (1993).
34. C. R. Jefcoate: Cytochrome P-450 enzymes in sterol biosynthesis and metabolism. In "Cytochrome P-450, Structure, Mechanism, and Biochemistry" (P. R. Ortiz de Montellano, ed.), pp. 387-428. Plenum Press, New York, 1986.
35. L. J. Ignarro, J. M. Fukuto, J. M. Griscavage, N. E. Rogers, and R. E. Byrns: Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from L-arginine. Proc. Natl. Acad. Sci. U.S.A. 90, 8103-8107 (1993).
36. I. M. C. M. Rietjens and J. Vervoort: Microsomal metabolism of fluoroanilines. Xenobiotica 19, 1297-1305 (1989).
37. I. M. C. M. Rietjens, B. Tyrakowska, C. Veeger, and J. Vervoort: Reaction pathways for biodehalogenation of fluorinated anilines. Eur. J. Biochem. 194, 945-954 (1990).
38. I. M. C. M. Rietjens and J. Vervoort: Bioactivation of 4-fluorinated anilines to benzoquinoneimines as primary reaction products. Chem.-Biol. Interact. 77, 263-281 (1991).
39. N. H. P. Cnubben, J. Vervoort, C. Veeger, and I. M. C. M. Rietjens: Study on the regioselectivity and mechanism of the aromatic hydroxylation of monofluoroanilines. Chem.-Biol. Interact. 85, 151-172 (1992).
40. N. H. P. Cnubben, S. Peelen, J.-W. Borst, J. Vervoort, C. Veeger, and I. M. C. M. Rietjens: Molecular orbital-based quantitative structure-activity relationship for the cytochrome P450-catalyzed 4-hydroxylation of halogenated anilines. Chem. Res. Toxicol. 7, 590-598 (1994).
41. N. H. P. Cnubben, J. Vervoort, M. G. Boersma, and I. M. C. M. Rietjens: The effect of varying halogen substituent patterns on the cytochrome P450 catalysed dehalogenation of 4-halogenated anilines to 4-aminophenol metabolites. Biochem. Pharmacol. 49, 1235-1248 (1995).